| Literature DB >> 36056171 |
Hugo Leite-Almeida1,2, Ioannis Sotiropoulos3,4,5, Sara R Guerreiro6,7, Marco R Guimarães6,7, Joana M Silva6,7, Chrysoula Dioli6,7,8, Anastasia Vamvaka-Iakovou8, Raquel Sousa6,7, Patrícia Gomes6,7, Anastasia Megalokonomou8,9, Carlos Campos-Marques6,7, Ana Margarida Cunha6,7, Armando Almeida6,7, Nuno Sousa6,7,10.
Abstract
Persistent pain has been recently suggested as a risk factor for dementia. Indeed, chronic pain is frequently accompanied by maladaptive brain plasticity and cognitive deficits whose molecular underpinnings are poorly understood. Despite the emerging role of Tau as a key regulator of neuronal plasticity and pathology in diverse brain disorders, the role of Tau has never been studied in the context of chronic pain. Using a peripheral (sciatic) neuropathy to model chronic pain in mice-spared nerve injury (SNI) for 4 months-in wildtype as well as P301L-Tau transgenic mice, we hereby demonstrate that SNI triggers AD-related neuropathology characterized by Tau hyperphosphorylation, accumulation, and aggregation in hippocampus followed by neuronal atrophy and memory deficits. Molecular analysis suggests that SNI inhibits autophagy and reduces levels of the Rab35, a regulator of Tau degradation while overexpression of Rab35 or treatment with the analgesic drug gabapentin reverted the above molecular changes leading to neurostructural and memory recovery. Interestingly, genetic ablation of Tau blocks the establishment of SNI-induced hippocampal morphofunctional deficits supporting the mediating role of Tau in SNI-evoked hippocampal pathology and memory impairment. These findings reveal that exposure to chronic pain triggers Tau-related neuropathology and may be relevant for understanding how chronic pain precipitates memory loss leading to dementia.Entities:
Year: 2022 PMID: 36056171 DOI: 10.1038/s41380-022-01707-3
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 13.437